Mass Psychology in action; Instead of Selling Gilead it is time to take a closer look

A little and a little, collected together, becomes a great deal; the heap in the barn consists of single grains, and drop and drop make the inundation. Saadi

One should be wary of listening to individuals that claim to be experts especially if they are associated with big investment firms or popular media. In most instances, the word expert is the code word for jackass, and the word sell is the secret code word for buy, especially if these jackasses are the ones telling you to do so. Before we continue, let’s examine the story below, and it clearly illustrates how those with the mass mindset sell when it is time to buy and buy when its time to sell.

Investors once OK with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress.There was a time when the underperformance of Gilead Sciences' (GILD) stock price was viewed as an opportunity to buy shares of a historically great biotech company at a discount.

But Gilead's stock price continues to fall, trading today where it did two years ago. The value play looks more like a trap. Investors once okay with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress. (I wrote about the challenges to Gilead's M&A growth strategy in July.)It's reaching the point now where Gilead CEO John Milligan (and before him, John Martin) is at risk of losing his perennial status as biotech's best, most trusted CEO.

"Investors have broadly lost confidence in management's ability to navigate the future competitive landscapes for its businesses and create value," wrote Piper Jaffray biotech analyst Josh Schimmer, in a research note on Gilead published this week. Full Story

GLD1.png

Look at the sentences that are boldfaced;  you can see the mass mindset in play. When we spot something like this, it starts to perk our interests as it usually signifies a bottom is close at hand. 

The chatter will probably increase before a bottom takes hold but at this point, those closing out their positions will probably regret this decision in the months and years to come. What these individuals forget is that nothing can trend up forever and this chart clearly illustrates that this stock has had a spectacular run. Thus the current consolidation is a long-term bullish development. The stock is letting out a well-deserved dose of steam and slowly building momentum for the next upward leg. 

There are two levels of support one that comes into play at; the first one falls in the 73.00-75.00 ranges, and the second one falls in the 63.00-65.00 ranges.   The second zone offers a stronger floor of support and would make a safer entry point.  

The five-year chart below illustrates that both the RSI and MACD’s are trading in the oversold ranges. While this does not mean that the stock has put in a bottom, it does indicate that the downside is going to be limited from here.

GLD2.png

Watch how the stock reacts on a test of 75.00; if it closes below this level on a weekly basis, then it is likely to test the 65.00 ranges. One idea would be to spread your money over various entry points which will help reduce your overall cost and won’t have you looking over your shoulder each step of the way.

Conclusion

Nature created the masses to serve as cannon fodder, and no matter what is done, nothing will change this. History is replete with examples of individuals who tried to help the masses; their only reward, in general, was the gallows or the bullet, depending on the era. It comes down to perception; you cannot force someone to latch on to yours and vice versa. This is why despite being one of the most hated bull markets in history, this bull market continues to trend higher because the masses refuse to embrace it. Thus consider this information as food for thought and not a recommendation to jump in and buy the stock.

Mass Psychology differs from contrarian investing; the driving force in Mass Psychology is that the focus is on extreme states. Contrarian investors tend to take an opposing position the moment the masses embrace a concept or market. Mass psychology does not follow that mandate; we wait for extreme conditions (panic or euphoria) before taking an opposing position.
While fear levels are rising, GILD probably needs to experience one more stage of selling before the masses move into the panic zone. This will likely coincide with a move to the 63-65 ranges. Gilead has shed roughly 35% from its high set in June 2015, so at this stage, you nee to ask yourself if it makes sense to sell

Big shots are only little shots who keep shooting.
Christopher Morley

Related

stocks

Biotech Phoenix is Rising

The expected pop in Biotech is well underway. I hope you didn’t miss it. It has the hallmarks of a...

April 08, 2016
stocks

Biotech Playing Catch Up

For the Nasdaq, Biotech is one of the ‘systemically important” sectors. Two Monday’s ago I wrote an...

April 04, 2016
stocks

Biotech: Printing A ‘W’ Bottom?

For the Nasdaq, Biotech is one of the most important sectors, as its market cap nearly rivals the FANG...

March 22, 2016
etfs

Biotech Could be Ready for Another Leg Lower

On Monday, VRX fell 18.4% on headlines that the company received a subpoena from the SEC.  While VRX is...

March 01, 2016